Depression Management Walkthrough

Depression · Clinical Walkthrough

What to do when an antidepressant isn’t working and the next step isn’t clear.

Work through the first decisions: was this a real trial, what kind of response you’re seeing, when to rethink the diagnosis—and what to do when the next step isn’t obvious.

Clinical scenario
Your patient has been on an antidepressant for a few weeks, but they’re not clearly better.

Symptoms persist, improvement is partial or unclear, and you’re deciding whether to wait, increase, switch, augment, or rethink the frame entirely.

The question is not just “is the patient better?” It is whether you have enough structure to decide what should happen next.

Takes about 2–3 minutes
Step 1 of 6
Is this actually a failed treatment?
Step 1

Is this actually a failed treatment?

Before changing anything, the first question is whether this has actually been a meaningful trial.

Quick orientation: a medication can look ineffective when it has not really had a chance to work.
  • Was the dose still low or only partially titrated?
  • Has enough time passed at a useful dose?
  • Has adherence been consistent enough to judge response?
  • Were expectations clear from the start?
The trap: calling a medication ineffective before you know whether it had a real trial.

You can recognize an incomplete trial — but when to wait, increase, or move on is less straightforward.

Step 2

What kind of “not better” are you seeing?

Not all non-response is the same. The pattern matters before the plan does.

General direction: no meaningful change may push toward changing strategy — but only if the trial was actually adequate.
General direction: partial response is different. It suggests there may be signal, but not yet enough benefit.
General direction: side effects change the decision because benefit and tolerability are now competing.
The trap: treating every “not better” patient the same, when no response, partial response, and tolerability problems should not lead to the same next step.
Step 3

Are you sure depression is the main problem?

When treatment is not working, it is worth reconsidering what you are actually treating.

Clinical anchor: if the frame is wrong, every medication decision downstream becomes distorted.
  • Anxiety, ADHD, substance use, or sleep problems may be driving symptoms.
  • Medical contributors or medications may be part of the picture.
  • Bipolar-spectrum history can change the risk calculation.
  • Chronic low mood may behave differently than an episodic major depressive episode.
The trap: escalating antidepressants when the diagnosis or driver is still uncertain.
Step 4

Which next move are you leaning toward?

At this point, several reasonable options may be on the table — and they do not all lead to the same outcome.

General direction: sometimes the right answer is a better trial of the medication already in front of you — but only if there is enough reason to keep going.
General direction: switching can be cleaner than layering on complexity — but the decision depends on whether the prior trial really failed.
General direction: augmentation can make sense when there is partial benefit — but not simply because “something has to change.”
The trap: choosing the next step based on frustration rather than the response pattern, side-effect burden, trial adequacy, and patient context.
Step 5

Why this is harder than it looks

In practice, these decisions rarely line up cleanly.

  • Partial improvement, but persistent functional impairment.
  • Some benefit, but increasing side effects.
  • No response, but an incomplete dose or adherence history.
  • A patient who wants to stop medication despite some improvement.
  • A history of “I’ve tried everything” without clear dose or duration details.
Different aspects of the clinical picture can point in different directions at the same time.
The trap: applying a simple rule in a multi-variable situation and ending up with decisions that feel reasonable, but do not consistently work.
Managing Depression PDF Download Step 5

Quick Reference

Not sure what to do after an incomplete response?

Get a short guide for sorting next step when response, side effects, dose, and diagnosis aren't pointing in the same direction.

Includes occasional clinical tools and updates. Unsubscribe anytime.

Step 6

This is where most approaches break down

By now, you are trying to combine several decisions at once.

Complexity checkpoint

You are weighing trial adequacy, response type, side effects, diagnosis, patient expectations, and whether to optimize, switch, augment, or escalate.

There are general principles for each of these decisions. But it can be hard to find clear, step-by-step algorithms for how to put them together consistently across visits.

  • You may know the options, but still be unsure which one fits this visit.
  • You may see partial improvement, but not know when it is enough to keep going.
  • You may move from one medication to the next without a clear threshold for changing course.
The trap: relying on isolated rules when what you need is a repeatable framework.
Next step

Continue with the full framework

You have seen the decision points. The harder part is knowing what to do when they do not all point in the same direction.

When has a medication actually had a real trial?
What counts as meaningful partial response?
How should you increase, switch, or augment?
When should you reconsider the diagnosis?
Managing Depression in Primary Care is a 1.5-hour audio course designed to give outpatient clinicians a structured way to approach depression care across visits — from diagnosis and initial treatment to non-response, adjustment, and longer-term management.
What the course helps you do
  • Clarify the diagnosis and avoid common pitfalls like grief, burnout, medical contributors, or vague “depression/anxiety” labeling.
  • Choose and start first-line treatment more deliberately.
  • Set expectations with patients so early response, side effects, and delayed benefit do not derail care.
  • Use a structured approach to deciding when to wait, increase, switch, augment, or escalate.
  • Bring in behavioral activation, psychotherapy, exercise, and higher-level options like TMS, ECT, or ketamine when the frame needs to broaden.
Learn it once, revisit it when you need it
Listen to the audio course through a private podcast feed while you’re on the go, or jump to specific sections when you want to hear the reasoning again.
Built for real visits

The workspace is designed to be pulled up mid-visit—so you can move from uncertainty to a clear next step without leaving the encounter.

  • Jump to the exact clinical question you’re facing
  • Open the relevant flowchart or algorithm
  • Review the reasoning behind the decision if needed

Includes: titration and augmentation flowcharts, medication selection tools, PHQ guide, differential checklist, side-effect guide, patient handouts and more.

$149
discounted from $179
Walkthrough-completion discount code: DEPRESSIONGUIDE30
You can use that code even if you view the full course page first and purchase afterward.
Preview the course Get the course for $149

If you want depression treatment decisions to feel less improvised — especially when the first medication does not produce a clean, obvious win — this is built for that.